Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

E-Cigarettes Could Up Respiratory Infection Risk

Vapor from electronic cigarettes may increase young people's risk of respiratory infections, regardless of whether or not it contains nicotine.

Aspirin-Exacerbated Respiratory Disease

Although previous numbers for aspirin-exacerbated respiratory disease (AERD) have varied widely, new findings suggest that it is present in approximately 7% of the adult asthmatic patient population, with that number doubled in patients with severe asthma.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Lung Infections May Hamper Cancer Detection

A test used to diagnose lung cancer may not be as reliable in geographic regions where certain lung infections are more common.

Fetal BPA Exposure and Childhood Wheeze

Exposure in pregnancy to bisphenol A (BPA) may increase a child's risk of respiratory issues, with a 10-fold increase in the average amount of BPA in the mothers' urine linked to a nearly 55% increase in the odds of some type of wheezing in their children.

Asthma Risk and Job Loss Fear

Perceived job insecurity during an economic downturn may increase the risk of newly onset asthma.

Sense of Smell May Predict Mortality

Olfaction could predict 5-year mortality risk among older adults, suggests a new study.

Asthma Treatments: Inhalations

Review this updated chart on inhalations for asthma treatment for quick information when you need it.

News

Viruses Driving Pneumonia Rates in Young Children

Young children are at increased risk of becoming seriously ill with pneumonia - but unlike in years past, the cause is usually a respiratory virus.

Dymista Granted Expanded Age Range

Meda announced that the Food and Drug Administration (FDA) has approved Dymista (azelastine HCl and fluticasone propionate) for the relief of symptoms of seasonal allergic rhinitis (SAR) in patients ages 6-11 who require treatment with both components.

Shorter FDA Review for Tx of Rare Lung Disorder

The Food and Drug Administration (FDA) has accepted for Priority Review a supplemental New Drug Application (sNDA) for Rapamune (sirolimus; Pfizer) for the treatment of lymphangioleiomyomatosis (LAM).

Can Snoring Be Treated With Pharmacotherapy?

Snoring can be indicative of increased upper airway resistance, a symptom of chronic sleep apnea, or associated with comorbidities such as obesity and hypothyroidism; it can also occur in the absence of any of these conditions (primary snoring).

Featured courses from mycme

Achieving and Sustaining Asthma Control in the Community SettingExternal web site

In this activity, experts will review the role of inflammation in both the large and ...

CME|CPE|CE 1.50 Credits

Asthma and COPD: Providing Optimal Management (Pharmacology Credit)External web site

This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...

CE 1.50 Credits

Sign Up for Free e-newsletters